Product Information
GABAPENTIN 300 MG CAPSULE is a generic product labeled by Laurus Labs Limited, priced at $0.0324 per EA under NDC 42385097305. Its NADAC has been published 72 times since Feb 12, 2025.
Strength
300 mg/1
Manufacturer
Laurus Labs LimitedNDC
42385097305
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA217546On Market Since
5/13/2023
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 300 MG CAPSULE has been published 72 times since Feb 12, 2025, and over the history we have for it it has declined 8.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0324 per EA |
|---|---|
| All-time high | $0.0367 (Mar 12, 2025) |
| All-time low | $0.0324 (Jun 17, 2026) |
| 52-week high | $0.0361 |
| 52-week low | $0.0324 |
| Median price | $0.0344 |
| Average price | $0.0345 |
| Largest weekly change | -4.4% (Apr 23, 2025) |
| Weeks tracked | 72 |
| Tracking since | Feb 12, 2025 |
Generic Alternatives
The matcher finds 17 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 300 MG CAPSULE, manufactured by Laurus Labs Limited, is $0.0324 per EA (NDC 42385097305), effective Jun 24, 2026.
How has the price of GABAPENTIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 300 MG CAPSULE has declined 8.2%. It has been tracked across 72 weekly CMS publications since Feb 12, 2025.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 300 MG CAPSULE?
Since Feb 12, 2025, the NADAC for GABAPENTIN 300 MG CAPSULE has ranged from a low of $0.0324 (Jun 17, 2026) to a high of $0.0367 (Mar 12, 2025), with a median of $0.0344 per EA.
Are there cheaper alternatives to GABAPENTIN 300 MG CAPSULE?
17 NADAC-published products share the same active ingredient, strength, and dosage form as GABAPENTIN 300 MG CAPSULE, but none are currently priced below it.
Who manufactures GABAPENTIN 300 MG CAPSULE?
GABAPENTIN 300 MG CAPSULE (NDC 42385097305) is labeled by Laurus Labs Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification